menu search

Relay therapeutics to announce second quarter 2023 financial results and corporate highlights on august 8, 2023

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision ...

August 1, 2023, 8:05 pm

Maxcyte signs strategic platform license with prime medicine to advance next-generation gene editing therapies for patients

Prime medicine to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to advance t...

August 1, 2023, 12:05 pm

Mgc pharmaceuticals proposes fundraising for australian investors

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) said it is looking to raise up to A$2.7 million (£1.39 million) via a share purchase plan for...

August 1, 2023, 7:59 am

Revolutin medicines to acquire eqrx in deal that will add $1 billion in cash to its balance sheet to fund r&d

Revolution Medicines Inc. RVMD, +2.10% said Tuesday it has reached a definitive agreement to acquire EQRx Inc. EQRX, in an all-cash deal that's expect...

August 1, 2023, 7:43 am

Amazon rolls out its virtual health clinic nationwide

Amazon Clinic allows patients to connect with telemedicine providers to help receive treatment for comm...

August 1, 2023, 6:01 am

Mineralys therapeutics to announce second quarter 2023 financial results and host conference call on monday, august 7, 2023

RADNOR, Pa., July 31, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on deve...

July 31, 2023, 4:05 pm

Athersys to host business update conference call on august 9th

CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a cell therapy and regenerative medicine com...

July 31, 2023, 1:38 pm

Booming veterinary wound care market driven by pet adoption and advancements in veterinary medicine, with an expected value of us$ 2.8 billion by 2023 | future market insights, inc.

The Veterinary Wound Care Market is set to experience significant growth, driven by pet healthcare and spending. As the awareness of proper wound mana...

July 31, 2023, 1:30 pm

Passage bio welcomes dolan sondhi, ph.d. to board of directors

PHILADELPHIA, July 31, 2023 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing tr...

July 31, 2023, 11:00 am

Better alzheimer's drug stock: eli lilly vs. biogen

Biogen and Eli Lilly are two major competitors in the field of Alzheimer's disease. Eli Lilly's medicine ...

July 31, 2023, 7:45 am

$pfe: buying weekly dips in pfizer before next big move

Pfizer, Inc. is an US American pharmaceutical and biotechnology company. Founded in 1849 and headquartered in New York, USA, it is a part of S&P100 an...

July 30, 2023, 12:52 am

Fulgent genetics: post-pandemic devaluing appears overdone

Fulgent Genetics is a technology-driven company focused on clinical diagnostics and therapeutics, with recent expansion into precision medicine. FLGT'...

July 29, 2023, 2:00 pm

2 healthcare stocks that could make you richer

As a producer of medicines for animals, Zoetis benefits from increased spending on pets. Thanks to a strong product line, Eli Lilly briefly ranked as ...

July 29, 2023, 9:30 am

Curium receives marketing authorization in the eu for pylclari™, an innovative 18f-psma pet tracer indicated in adults with prostate cancer

PARIS, July 28, 2023 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced that the European Commission has granted marketing aut...

July 28, 2023, 10:12 am

Astrazeneca number show how it is 'not a one-trick pony' - analyst

AstraZeneca PLC's (LSE:AZN) underlying quarterly performance shows it is "far from a one-trick pony" and its share price premium over peers is entire...

July 28, 2023, 8:23 am

Astrazeneca unit strikes $1bn rare diseases deal with pfizer

AstraZeneca PLC's rare disease unit, Alexion, has unveiled a $1 billion agreement to acquire Pfizer's early-stage gene therapy portfolio, a strategic...

July 28, 2023, 2:41 am

Takeda says it has 40 clinical-stage medicines in the pipeline

Christophe Weber, CEO of Takeda, says there are some setbacks in research and development, but most of those drugs should fuel the company's growth in...

July 28, 2023, 12:46 am

Wave life sciences second quarter 2023 financial results scheduled for august 3, 2023

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delive...

July 27, 2023, 12:30 pm

Gelatin methacryloyl market to reach usd 309.0 million by 2031, growing at a cagr of 6.6% from 2023-2031: tmr report

Surging demand driven by bioprinting advancements and regenerative medicine breakthroughs. Biocompatibi...

July 27, 2023, 10:46 am

The u.s.' inflation reduction act risks hampering innovation, says roche ceo

Roche CEO Thomas Schinecker warns that sections of the U.S. Inflation Reduction Act could stifle the development of new medicines....

July 27, 2023, 8:11 am


Search within

Pages Search Results: